澳大利亚国家目标人群甲型肝炎免疫规划的影响:2000-2014年
2005年11月起,澳大利亚在昆士兰州、南澳大利亚州、西澳大利亚州和北领地针对12-24月龄原住民儿童资助甲肝疫苗。本研究利用国家法定传染病监测系统、医院发病率和死因数据,比较2000-2005年与2006-2014年各年龄组、原住民身份及辖区的发病率比。
要点
- 原住民甲肝通知率从接种前8.41/10万降至接种后0.85/10万,接近非原住民水平。
- 目标辖区原住民5岁以下儿童通知IRR=0.07,住院IRR=0.04。
- 目标辖区非原住民通知率总体IRR=0.43,高于非目标辖区IRR=0.60。
核心结论
- 国家甲肝免疫规划对目标人群产生显著影响,疫苗覆盖率相对适度,证据提示存在实质性群体保护效应。
研究设计与样本
- 利用澳大利亚国家法定传染病监测系统、国家医院发病率数据库和澳大利亚统计局死因数据,对2000-2014年甲肝流行病学进行回顾性分析,比较接种前(2000-2005年)与接种后(2006-2014年)按年龄组、原住民身份和辖区划分的发病率比(IRR)。
主要发现
- 全国原住民接种前通知率为8.41/10万(95%CI 5.03-11.79),接种后降至0.85/10万(95%CI 0.00-1.99),接种前是非原住民的4倍,接种后与非原住民相似。
- 目标辖区原住民5岁以下儿童接种后通知IRR=0.07(95%CI 0.04-0.13),住院IRR=0.04(95%CI 0.01-0.16)。
- 目标辖区原住民5-19岁通知IRR=0.08(95%CI 0.05-0.13),20-49岁通知IRR=0.06(95%CI 0.02-0.15)。
- 目标辖区非原住民5岁以下儿童通知IRR=0.47(95%CI 0.31-0.71),总体IRR=0.43(95%CI 0.39-0.47),非目标辖区非原住民总体IRR=0.60(95%CI 0.56-0.64)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In November 2005, hepatitis A vaccine was funded under the Australian National Immunisation Program for Aboriginal and Torres Strait Islander (Indigenous) children aged 12-24months in the targeted jurisdictions of Queensland, South Australia, Western Australia and the Northern Territory. We reviewed the epidemiology of hepatitis A from 2000 to 2014 using data from the Australian National Notifiable Diseases Surveillance System, the National Hospital Morbidity Database, and Australian Bureau of Statistics causes-of-death data. The impact of the national hepatitis A immunisation program was assessed by comparison of pre-vaccine (2000-2005) and post-vaccine time periods (2006-2014), by age group, Indigenous status and jurisdiction using incidence rate ratios (IRR) per 100,000 population and 95% confidence intervals (CI). The national pre-vaccine notification rate in Indigenous people was four times higher than the non-Indigenous rate, and declined from 8.41 per 100,000 (95% CI 5.03-11.79) pre-vaccine to 0.85 per 100,000 (95% CI 0.00-1.99) post-vaccine, becoming similar to the non-Indigenous rate. Notification and hospitalisation rates in Indigenous children aged <5years from targeted jurisdictions declined in the post-vaccine period when compared to the pre-vaccine period (notifications: IRR=0.07; 95% CI 0.04-0.13; hospitalisations: IRR=0.04; 95% CI 0.01-0.16). As did notification rates in Indigenous people aged 5-19 (IRR=0.08; 95% CI 0.05-0.13) and 20-49years (IRR=0.06; 95% CI 0.02-0.15) in targeted jurisdictions. For non-Indigenous people from targeted jurisdictions, notification rates decreased significantly in children aged <5years (IRR 0.47; 95% CI 0.31-0.71), and significantly more overall (IRR=0.43; 95% CI 0.39-0.47) compared to non-Indigenous people from non-targeted jurisdictions (IRR=0.60; 95% CI 0.56-0.64). The national hepatitis A immunisation program has had a significant impact in the targeted population with relatively modest vaccine coverage, with evidence suggestive of substantial herd protection effects.
引用
- Thompson C, Dey A, Fearnley E, et al. Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014. Vaccine. 2016. PMID: 27876203. doi:10.1016/j.vaccine.2016.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。